Many Patients with Anal Cancer Experienced Chemoradiation Therapy Interruption and Noncompletion

A recent study published in JAMA Oncology revealed that quality improvement initiatives are necessary to optimize treatment and lessen chemotherapy interruption and noncompletion rates among patients with squamous cell anal carcinoma.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news